OrbiMed Advisors and Deerfield’s $40 Million Follow-On Financing Agreement With Valneva

Bryan Cave Leighton Paisner (BCLP) has advised two U.S. healthcare investment funds, Orbimed Advisors and Deerfield Management Company. Valneva was advised in France by Hogan Lovells (Paris) LLP. In the US, Valneva was advised by Dechert LLP.

This agreement completes an initial agreement of February 2020 between the above two funds and Valneva by increasing the amount in principal of the 2020 agreement.

Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden and Vienna, Austria, with other offices in France, Canada and the United States. 

Orbimed Advisors and Deerfield Management Company were advised in France by Bryan Cave Leighton Paisner (BCLP) Paris with a team composed of Corporate Partner Christian Sauer (Picture), Partner Olivier Borenstejn and Associate Aliou Wone in financing. In the US the investment funds were advised by Covington & Burling LLP.

The Hogan Lovells team was composed of Jean Marc Franceschi, Corporate Partner, Sophie Lok, Counsel, Ouassila El Asri and Diane Ferriol, Financing Associates.  


Involved fees earner: Olivier Borenstejn – Bryan Cave Leighton Paisner; Christian Sauer – Bryan Cave Leighton Paisner; Ouassila El Asri – Hogan Lovells; Diane Ferriol – Hogan Lovells; Jean-Marc Franceschi – Hogan Lovells; Sophie Lok – Hogan Lovells;

Law Firms: Bryan Cave Leighton Paisner; Hogan Lovells;

Clients: Deerfield Management Company, L.P.; OrbiMed; Valneva;

Giulia Di Palma

Author: Giulia Di Palma